Targacept, Inc. To Present At The 13th Annual Needham Healthcare Conference

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Targacept, Inc. (NASDAQ: TRGT), a clinical-stage biopharmaceutical company developing novel NNR Therapeutics™, today announced that Dr. Stephen A. Hill, President and Chief Executive Officer, is scheduled to present at the 13th Annual Needham Healthcare Conference at the Westin New York Grand Central Hotel in New York City on Wednesday, April 9, 2014 at 1:40 p.m. Eastern Time.

Help employers find you! Check out all the jobs and post your resume.

Back to news